Which companies overlap with Centre for the AIDS Programme of Research in South Africa's portfolio?

Top competitors by shared drug class: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/centre-for-the-aids-programme-of-research-in-south-africa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Centre for the AIDS Programme of Research in South Africa — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Centre for the AIDS Programme of Research in South Africa pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tenofovir, lamivudine and efavirenz	Tenofovir, lamivudine and efavirenz	marketed	Antiretroviral combination therapy (NRTI/NtRTI + NNRTI)	HIV reverse transcriptase, HIV integrase	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Centre for the AIDS Programme of Research in South Africa:

Cite this brief

Drug Landscape (2026). Centre for the AIDS Programme of Research in South Africa — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centre-for-the-aids-programme-of-research-in-south-africa. Accessed 2026-05-18.